Anavex Life Sciences AVXL
NASDAQ AVXL
$1.33 -0.03 (-2.21%)
At close: Oct 23, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Change in Other Operating Liabilities (2021 - 2022)

Updated

Analysis

Anavex Life Sciences (AVXL) Change in Other Operating Liabilities (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 2.69 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -112.00 Mn
10 Anavex Life Sciences 123.29 Mn -356.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 473,000.00
Jun 30, 2021 -43,280.00
API Access

Anavex Life Sciences Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=AVXL&period=max&api_key=YOUR_API_KEY